155 related articles for article (PubMed ID: 33902246)
21. High-dose erlotinib for refractory leptomeningeal metastases after failure of standard-dose EGFR-TKIs.
Kawamura T; Hata A; Takeshita J; Fujita S; Hayashi M; Tomii K; Katakami N
Cancer Chemother Pharmacol; 2015 Jun; 75(6):1261-6. PubMed ID: 25921002
[TBL] [Abstract][Full Text] [Related]
22. [Spinal metastases combined with leptomeningeal metastasis: A case report].
Ma LJ; Hu PP; Liu XG
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):563-566. PubMed ID: 37291936
[TBL] [Abstract][Full Text] [Related]
23. [Investigation of Methods and Influencing Factors to Increase the Positive Rate of
Cytological Pathology of Cerebrospinal Fluid from Lung Cancer Leptomeningeal Metastases].
Gao N; Teng C; Fan C; Xin T
Zhongguo Fei Ai Za Zhi; 2022 Nov; 25(11):789-796. PubMed ID: 36419392
[TBL] [Abstract][Full Text] [Related]
24. Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases.
Diaz M; Singh P; Kotchetkov IS; Skakodub A; Meng A; Tamer C; Young RJ; Reiner AS; Panageas KS; Ramanathan LV; Pentsova E
J Neurooncol; 2022 Mar; 157(1):81-90. PubMed ID: 35113288
[TBL] [Abstract][Full Text] [Related]
25. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
26. Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer.
Gwak HS; Joo J; Kim S; Yoo H; Shin SH; Han JY; Kim HT; Lee JS; Lee SH
J Thorac Oncol; 2013 May; 8(5):599-605. PubMed ID: 23422833
[TBL] [Abstract][Full Text] [Related]
27. [Clinical features and prognostic factors in patients with leptomeningeal metastases].
Li N; Yang BY; Li JL; Zhu JQ; Zou BH; Wang YF; Yu L; Yao XY
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):867-70. PubMed ID: 24447488
[TBL] [Abstract][Full Text] [Related]
28. Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study.
Mitsuya K; Nakasu Y; Hayashi N; Deguchi S; Takahashi T; Murakami H; Naito T; Kenmotsu H; Ono A; Wakuda K; Harada H
PLoS One; 2019; 14(1):e0210074. PubMed ID: 30629621
[TBL] [Abstract][Full Text] [Related]
29. Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer.
Ko Y; Gwak HS; Park EY; Joo J; Lee YJ; Lee SH; Kwon JW; Shin SH; Yoo H
J Neurooncol; 2019 Jul; 143(3):553-562. PubMed ID: 31089925
[TBL] [Abstract][Full Text] [Related]
30. Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis.
Huang R; Ge M; Zhou X; Ji X; Liao L; Liang X; Zhan Q
Cancer Biother Radiopharm; 2019 Mar; 34(2):128-133. PubMed ID: 30452286
[TBL] [Abstract][Full Text] [Related]
31. Leptomeningeal metastases in non-small cell lung cancer: Diagnosis and treatment.
Wang Y; Yang X; Li NJ; Xue JX
Lung Cancer; 2022 Dec; 174():1-13. PubMed ID: 36206679
[TBL] [Abstract][Full Text] [Related]
32. Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy.
Morris PG; Reiner AS; Szenberg OR; Clarke JL; Panageas KS; Perez HR; Kris MG; Chan TA; DeAngelis LM; Omuro AM
J Thorac Oncol; 2012 Feb; 7(2):382-5. PubMed ID: 22089116
[TBL] [Abstract][Full Text] [Related]
33. Leptomeningeal Carcinomatosis in Colorectal Cancer: The Mayo Clinic Experience.
Taylor G; Karlin N; Halfdanarson TR; Coppola K; Grothey A
Clin Colorectal Cancer; 2018 Jun; 17(2):e183-e187. PubMed ID: 29221687
[TBL] [Abstract][Full Text] [Related]
34. Classification of Leptomeningeal Metastases from Solid Organ Malignancies and Clinical Outcomes: Series from a Cancer Research Centre.
Deepak S; Lima A; Rajat S; Meenu W
Indian J Surg Oncol; 2020 Jun; 11(2):308-312. PubMed ID: 32523280
[TBL] [Abstract][Full Text] [Related]
35. Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases.
Flippot R; Biondani P; Auclin E; Xiao D; Hendriks L; Le Rhun E; Leduc C; Beau-Faller M; Gervais R; Remon J; Adam J; Planchard D; Lavaud P; Naltet C; Caramella C; Le Pechoux C; Lacroix L; Gazzah A; Mezquita L; Besse B
J Thorac Oncol; 2019 Aug; 14(8):1400-1407. PubMed ID: 31108248
[TBL] [Abstract][Full Text] [Related]
36. A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer.
Nevel KS; DiStefano N; Lin X; Skakodub A; Ogilvie SQ; Reiner AS; Pentsova E; Boire A
Neuro Oncol; 2020 May; 22(5):675-683. PubMed ID: 32352148
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY; Chung WK; Oh IJ
Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier
Integrity in Lung Cancer Patients with Leptomeningeal Metastasis].
Lin Y; Yu T; Li H; Yin Z; Guo A
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):567-576. PubMed ID: 34120432
[TBL] [Abstract][Full Text] [Related]
39. The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer.
Wang Y; Luo N; Gao Y; Wu Y; Qin X; Qi Y; Sun T; Tao R; Qi C; Liu B; Yuan S
J Cancer Res Clin Oncol; 2023 May; 149(5):1679-1690. PubMed ID: 35583828
[TBL] [Abstract][Full Text] [Related]
40. [Advances in Diagnosis and Treatment of Leptomeningeal Metastasis of Lung Cancer].
Gao N; Xin T
Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):517-523. PubMed ID: 35899451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]